Intravitreal Ivt Injectable Market
Intravitreal Ivt Injectable Market : Table of Content
- Report code : PMRREP25906 |
- Industry : Life Sciences & Transformational Health |
- Published On : Feb-2019 |
- Pages : 276 Pages |
-
Format :
1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
2. Market Introduction
2.1. Market Taxonomy
2.2. Market Definition
3. Key Inclusions and Exclusions
4. Market Opportunity Analysis
4.1. Macro-Economic Factors
4.2. Opportunity Analysis
5. Market Dynamics
5.1. Drivers
5.1.1. Supply Side Drivers
5.1.2. Demand Side Drivers
5.2. Restraints
5.3. Trends
6. Epidemiology Analysis
7. Reimbursement Guidelines
8. Pipeline Analysis
9. Global Economic Outlook
9.1. Gross Domestic Indication Type by Region & Country, 2006 – 2021
9.2. Global Healthcare Market Indicators
10. Global Intravitreal (IVT) Injectables Market Analysis 2013-2017 and Forecast 2018-2028, by Drug Class
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) By Drug Class, 2013 - 2017
10.2.1. Anti-VEGF
10.2.2. Corticosteroids
10.2.3. Antibiotics
10.2.4. Antivirals
10.2.5. Antifungals
10.3. Market Size (US$ Mn) Forecast By Drug Class, 2018-2028
10.4. Market Attractiveness Analysis By Drug Class
11. Global Intravitreal (IVT) Injectables Market Analysis 2013-2017 and Forecast 2018-2028, by Indication
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) By Indication, 2013 - 2017
11.2.1. Diabetic Retinopathy
11.2.2. Macular Degeneration
11.2.3. Endophthalmitis
11.2.4. Retinal Vein Occlusions
11.2.5. Others
11.3. Market Size (US$ Mn) Forecast By Indication, 2018-2028
11.4. Market Attractiveness Analysis By Indication
12. Global Intravitreal (IVT) Injectables Market Analysis 2013-2017 and Forecast 2018-2028, by Distributional Channel
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) By Distributional Channel, 2013 - 2017
12.2.1. Hospital Pharmacies
12.2.2. Retail Pharmacies
12.2.3. Drug Stores
12.2.4. Mail Order Pharmacies
12.2.5. Others
12.3. Market Size (US$ Mn) Forecast By Distributional Channel, 2018-2028
12.4. Market Attractiveness Analysis By Distributional Channel
13. Global Intravitreal (IVT) Injectables Market Analysis 2013-2017 and Forecast 2018-2028, by Region
13.1. Introduction
13.2. Historical Market Size (US$ Mn) By Region, 2013 - 2017
13.2.1. North America
13.2.2. Latin America
13.2.3. Europe
13.2.4. South Asia
13.2.5. East Asia
13.2.6. Oceania
13.2.7. Middle East and Africa
13.2.8. Emerging Countries
13.3. Market Size (US$ Mn) Forecast By Region, 2018-2028
13.4. Market Attractiveness Analysis By Region
14. North America Intravitreal (IVT) Injectables Market Analysis 2013-2017 and Forecast 2018-2028
14.1. Introduction
14.2. Historical Market Size (US$ Mn) and By Country, 2013 – 2017
14.2.1. U.S.
14.2.2. Canada
14.3. Market Size (US$ Mn) Forecast By Country, 2018-2028
14.4. Historical Market Size (US$ Mn) and Trend Analysis By Drug Class, 2013-2017
14.4.1. Anti-VEGF
14.4.2. Corticosteriods
14.4.3. Antibiotics
14.4.4. Antivirals
14.4.5. Antifungals
14.5. Market Size (US$ Mn) Forecast By Drug Class, 2018-2028
14.6. Historical Market Size (US$ Mn) and Trend Analysis By Indication, 2013-2017
14.6.1. Diabetic Retinopathy
14.6.2. Macular Degeneration
14.6.3. Endophthalmitis
14.6.4. Retinal Vein Occlusion
14.6.5. Others
14.7. Market Size (US$ Mn) Forecast By Indication, 2018-2028
14.8. Historical Market Size (US$ Mn) and Trend Analysis By Distributional Channel, 2013- 2017
14.8.1. Hospital Pharmacies
14.8.2. Retail Pharmacies
14.8.3. Drug Stores
14.8.4. Mail Order Pharmacies
14.8.5. Others
14.9. Market Size (US$ Mn) Forecast By Distributional Channel, 2018-2028
14.10. Market Attractiveness Analysis
14.10.1. By Country
14.10.2. By Drug Class
14.10.3. By Indication
14.10.4. By Distributional Channel
14.11. Drivers and Restraints: Impact Analysis
15. Latin America Intravitreal (IVT) Injectables Market Analysis 2013-2017 and Forecast 2018-2028
15.1. Introduction
15.2. Historical Market Size (US$ Mn) and Analysis By Country, 2013 - 2017
15.2.1. Brazil
15.2.2. Mexico
15.2.3. Rest of Latin America
15.3. Market Size (US$ Mn) Forecast By Country, 2018-2028
15.4. Historical Market Size (US$ Mn) and Trend Analysis By Drug Class, 2013-2017
15.4.1. Anti-VEGF
15.4.2. Corticosteriods
15.4.3. Antibiotics
15.4.4. Antivirals
15.4.5. Antifungals
15.5. Market Size (US$ Mn) Forecast By Drug Class, 2018-2028
15.6. Historical Market Size (US$ Mn) and Trend Analysis By Indication, 2013-2017
15.6.1. Diabetic Retinopathy
15.6.2. Macular Degeneration
15.6.3. Endophthalmitis
15.6.4. Retinal Vein Occlusion
15.6.5. Others
15.7. Market Size (US$ Mn) Forecast By Indication, 2018-2028
15.8. Historical Market Size (US$ Mn) and Trend Analysis By Distributional Channel, 2013- 2017
15.8.1. Hospital Pharmacies
15.8.2. Retail Pharmacies
15.8.3. Drug Stores
15.8.4. Mail Order Pharmacies
15.8.5. Others
15.9. Market Size (US$ Mn) Forecast By Distributional Channel, 2018-2028
15.10. Market Attractiveness Analysis
15.10.1. By Country
15.10.2. By Drug Class
15.10.3. By Indication
15.10.4. By Distributional Channel
15.11. Drivers and Restraints: Impact Analysis
16. Europe Intravitreal (IVT) Injectables Market Analysis 2013-2017 and Forecast 2018-2028
16.1. Introduction
16.2. Historical Market Size (US$ Mn) and Analysis By Country, 2013 - 2017
16.2.1. Germany
16.2.2. Italy
16.2.3. France
16.2.4. U.K.
16.2.5. Spain
16.2.6. BENELUX
16.2.7. Russia
16.2.8. Rest of Europe
16.3. Market Size (US$ Mn) Forecast By Country, 2018-2028
16.4. Historical Market Size (US$ Mn) and Trend Analysis By Drug Class, 2013-2017
16.4.1. Anti-VEGF
16.4.2. Corticosteriods
16.4.3. Antibiotics
16.4.4. Antivirals
16.4.5. Antifungals
16.5. Market Size (US$ Mn) Forecast By Drug Class, 2018-2028
16.6. Historical Market Size (US$ Mn) and Trend Analysis By Indication, 2013-2017
16.6.1. Diabetic Retinopathy
16.6.2. Macular Degeneration
16.6.3. Endophthalmitis
16.6.4. Retinal Vein Occlusion
16.6.5. Others
16.7. Market Size (US$ Mn) Forecast By Indication, 2018-2028
16.8. Historical Market Size (US$ Mn) and Trend Analysis By Distributional Channel, 2013- 2017
16.8.1. Hospital Pharmacies
16.8.2. Retail Pharmacies
16.8.3. Drug Stores
16.8.4. Mail Order Pharmacies
16.8.5. Others
16.9. Market Size (US$ Mn) Forecast By Distributional Channel, 2018-2028
16.10. Market Attractiveness Analysis
16.10.1. By Country
16.10.2. By Drug Class
16.10.3. By Indication
16.10.4. By Distributional Channel
16.11. Drivers and Restraints: Impact Analysis
17. South Asia Intravitreal (IVT) Injectables Market Analysis 2013-2017 and Forecast 2018-2028
17.1. Introduction
17.2. Historical Market Size (US$ Mn) and Analysis By Country, 2013 - 2017
17.2.1. India
17.2.2. Thailand
17.2.3. Indonesia
17.2.4. Malaysia
17.2.5. Rest of South Asia
17.3. Market Size (US$ Mn) Forecast By Country, 2018-2028
17.4. Historical Market Size (US$ Mn) and Trend Analysis By Drug Class, 2013-2017
17.4.1. Anti-VEGF
17.4.2. Corticosteriods
17.4.3. Antibiotics
17.4.4. Antivirals
17.4.5. Antifungals
17.5. Market Size (US$ Mn) Forecast By Drug Class, 2018-2028
17.6. Historical Market Size (US$ Mn) and Trend Analysis By Indication, 2013-2017
17.6.1. Diabetic Retinopathy
17.6.2. Macular Degeneration
17.6.3. Endophthalmitis
17.6.4. Retinal Vein Occlusion
17.6.5. Others
17.7. Market Size (US$ Mn) Forecast By Indication, 2018-2028
17.8. Historical Market Size (US$ Mn) and Trend Analysis By Distributional Channel, 2013- 2017
17.8.1. Hospital Pharmacies
17.8.2. Retail Pharmacies
17.8.3. Drug Stores
17.8.4. Mail Order Pharmacies
17.8.5. Others
17.9. Market Size (US$ Mn) Forecast By Distributional Channel, 2018-2028
17.10. Market Attractiveness Analysis
17.10.1. By Country
17.10.2. By Drug Class
17.10.3. By Indication
17.10.4. By Distributional Channel
17.11. Drivers and Restraints: Impact Analysis
18. East Asia Intravitreal (IVT) Injectables Market Analysis 2013-2017 and Forecast 2018-2028
18.1. Introduction
18.2. Historical Market Size (US$ Mn) and Analysis By Country, 2013 - 2017
18.2.1. China
18.2.2. Japan
18.2.3. South Korea
18.3. Market Size (US$ Mn) Forecast By Country, 2018-2028
18.4. Historical Market Size (US$ Mn) and Trend Analysis By Drug Class, 2013-2017
18.4.1. Anti-VEGF
18.4.2. Corticosteriods
18.4.3. Antibiotics
18.4.4. Antivirals
18.4.5. Antifungals
18.5. Market Size (US$ Mn) Forecast By Drug Class, 2018-2028
18.6. Historical Market Size (US$ Mn) and Trend Analysis By Indication, 2013-2017
18.6.1. Diabetic Retinopathy
18.6.2. Macular Degeneration
18.6.3. Endophthalmitis
18.6.4. Retinal Vein Occlusion
18.6.5. Others
18.7. Market Size (US$ Mn) Forecast By Indication, 2018-2028
18.8. Historical Market Size (US$ Mn) and Trend Analysis By Distributional Channel, 2013- 2017
18.8.1. Hospital Pharmacies
18.8.2. Retail Pharmacies
18.8.3. Drug Stores
18.8.4. Mail Order Pharmacies
18.8.5. Others
18.9. Market Size (US$ Mn) Forecast By Distributional Channel, 2018-2028
18.10. Market Attractiveness Analysis
18.10.1. By Country
18.10.2. By Drug Class
18.10.3. By Indication
18.10.4. By Distributional Channel
18.11. Drivers and Restraints: Impact Analysis
19. Oceania Intravitreal (IVT) Injectables Market Analysis 2013-2017 and Forecast 2018-2028
19.1. Introduction
19.2. Historical Market Size (US$ Mn) and Analysis By Country, 2013 - 2017
19.2.1. Australia
19.2.2. New Zealand
19.3. Market Size (US$ Mn) Forecast By Country, 2018-2028
19.4. Historical Market Size (US$ Mn) and Trend Analysis By Drug Class, 2013-2017
19.4.1. Anti-VEGF
19.4.2. Corticosteriods
19.4.3. Antibiotics
19.4.4. Antivirals
19.4.5. Antifungals
19.5. Market Size (US$ Mn) Forecast By Drug Class, 2018-2028
19.6. Historical Market Size (US$ Mn) and Trend Analysis By Indication, 2013-2017
19.6.1. Diabetic Retinopathy
19.6.2. Macular Degeneration
19.6.3. Endophthalmitis
19.6.4. Retinal Vein Occlusion
19.6.5. Others
19.7. Market Size (US$ Mn) Forecast By Indication, 2018-2028
19.8. Historical Market Size (US$ Mn) and Trend Analysis By Distributional Channel, 2013- 2017
19.8.1. Hospital Pharmacies
19.8.2. Retail Pharmacies
19.8.3. Drug Stores
19.8.4. Mail Order Pharmacies
19.8.5. Others
19.9. Market Size (US$ Mn) Forecast By Distributional Channel, 2018-2028
19.10. Market Attractiveness Analysis
19.10.1. By Country
19.10.2. By Drug Class
19.10.3. By Indication
19.10.4. By Distributional Channel
19.11. Drivers and Restraints: Impact Analysis
20. Middle East and Africa Intravitreal (IVT) Injectables Market Analysis 2013-2017 and Forecast 2018-2028
20.1. Introduction
20.2. Historical Market Size (US$ Mn) and Analysis By Country, 2013 - 2017
20.2.1. GCC Countries
20.2.2. Turkey
20.2.3. Northern Africa
20.2.4. South Africa
20.2.5. Rest of Middle East and Africa
20.3. Market Size (US$ Mn) Forecast By Country, 2018-2028
20.4. Historical Market Size (US$ Mn) and Trend Analysis By Drug Class, 2013-2017
20.4.1. Anti-VEGF
20.4.2. Corticosteriods
20.4.3. Antibiotics
20.4.4. Antivirals
20.4.5. Antifungals
20.5. Market Size (US$ Mn) Forecast By Drug Class, 2018-2028
20.6. Historical Market Size (US$ Mn) and Trend Analysis By Indication, 2013-2017
20.6.1. Diabetic Retinopathy
20.6.2. Macular Degeneration
20.6.3. Endophthalmitis
20.6.4. Retinal Vein Occlusion
20.6.5. Others
20.7. Market Size (US$ Mn) Forecast By Indication, 2018-2028
20.8. Historical Market Size (US$ Mn) and Trend Analysis By Distributional Channel, 2013- 2017
20.8.1. Hospital Pharmacies
20.8.2. Retail Pharmacies
20.8.3. Drug Stores
20.8.4. Mail Order Pharmacies
20.8.5. Others
20.9. Market Size (US$ Mn) Forecast By Distributional Channel, 2018-2028
20.10. Market Attractiveness Analysis
20.10.1. By Country
20.10.2. By Drug Class
20.10.3. By Indication
20.10.4. By Distributional Channel
20.11. Drivers and Restraints: Impact Analysis
21. Emerging Countries Intravitreal (IVT) Injectables Market Analysis 2013-2017 and Forecast 2018-2028
21.1. Introduction
21.2. Global Vs. Country Growth Comparison
22. China Intravitreal Injectables (IVT) Market Analysis 2013–2017 and Forecast 2018–2028
22.1. Introduction
22.2. Historical Market Size (US$ Mn) and Trend Analysis By Drug Class, 2013-2017
22.2.1. Anti-VEGF
22.2.2. Corticosteriods
22.2.3. Antibiotics
22.2.4. Antivirals
22.2.5. Antifungals
22.2.6. Market Size (US$ Mn) Forecast By Drug Class, 2018-2028
22.3. Historical Market Size (US$ Mn) and Trend Analysis By Indication, 2013-2017
22.3.1. Diabetic Retinopathy
22.3.2. Macular Degeneration
22.3.3. Endophthalmitis
22.3.4. Retinal Vein Occlusion
22.3.5. Others
22.4. Market Size (US$ Mn) Forecast By Indication, 2018-2028
22.5. Historical Market Size (US$ Mn) and Trend Analysis By Distributional Channel, 2013- 2017
22.5.1. Hospital Pharmacies
22.5.2. Retail Pharmacies
22.5.3. Drug Stores
22.5.4. Mail Order Pharmacies
22.5.5. Others
22.6. Market Size (US$ Mn) Forecast By Distributional Channel, 2018-2028
22.7. Market Attractiveness Analysis
22.7.1. By Country
22.7.2. By Drug Class
22.7.3. By Indication
22.7.4. By Distributional Channel
22.8. PESTLE Analysis
22.9. Drivers and Restraints: Impact Analysis
23. India Intravitreal Injectables (IVT) Market Analysis 2013–2017 and Forecast 2018–2028
23.1. Introduction
23.2. Historical Market Size (US$ Mn) and Trend Analysis By Drug Class, 2013-2017
23.2.1. Anti-VEGF
23.2.2. Corticosteriods
23.2.3. Antibiotics
23.2.4. Antivirals
23.2.5. Antifungals
23.3. Market Size (US$ Mn) Forecast By Drug Class, 2018-2028
23.4. Historical Market Size (US$ Mn) and Trend Analysis By Indication, 2013-2017
23.4.1. Diabetic Retinopathy
23.4.2. Macular Degeneration
23.4.3. Endophthalmitis
23.4.4. Retinal Vein Occlusion
23.3.5. Others
23.5. Market Size (US$ Mn) Forecast By Indication, 2018-2028
23.6. Historical Market Size (US$ Mn) and Trend Analysis By Distributional Channel, 2013- 2017
23.5.1. Hospital Pharmacies
23.5.2. Retail Pharmacies
23.5.3. Drug Stores
23.5.4. Mail Order Pharmacies
23.5.5. Others
23.6. Market Size (US$ Mn) Forecast By Distributional Channel, 2018-2028
23.7. Market Attractiveness Analysis
23.7.1. By Country
23.7.2. By Drug Class
23.7.3. By Indication
23.7.4. By Distributional Channel
23.8. PESTLE Analysis
23.9. Drivers and Restraints: Impact Analysis
24. Mexico Intravitreal Injectables (IVT) Market Analysis 2013–2017 and Forecast 2018–2028
24.1. Introduction
24.2. Historical Market Size (US$ Mn) and Trend Analysis By Drug Class, 2013-2017
24.2.1. Anti-VEGF
24.2.2. Corticosteriods
24.2.3. Antibiotics
24.2.4. Antivirals
24.2.5. Antifungals
24.2. Market Size (US$ Mn) Forecast By Drug Class, 2018-2028
24.3. Historical Market Size (US$ Mn) and Trend Analysis By Indication, 2013-2017
24.3.1. Diabetic Retinopathy
24.3.2. Macular Degeneration
24.3.3. Endophthalmitis
24.3.4. Retinal Vein Occlusion
24.3.5. Others
24.4. Market Size (US$ Mn) Forecast By Indication, 2018-2028
24.5. Historical Market Size (US$ Mn) and Trend Analysis By Distributional Channel, 2013- 2017
24.5.1. Hospital Pharmacies
24.5.2. Retail Pharmacies
24.5.3. Drug Stores
24.5.4. Mail Order Pharmacies
24.5.5. Others
24.6. Market Size (US$ Mn) Forecast By Distributional Channel, 2018-2028
24.7. Market Attractiveness Analysis
24.7.1. By Country
24.7.2. By Drug Class
24.7.3. By Indication
24.7.4. By Distributional Channel
24.8. PESTLE Analysis
24.9. Drivers and Restraints: Impact Analysis
25. Forecast Factors: Relevance and Impact
26. Forecast Assumptions
27. Competition Analysis
27.1. Competition Dashboard
27.2. Competition Deep Dive
27.2.1. F. Hoffmann-La Roche Ltd
27.2.1.1. Overview
27.2.1.2. Key Financials
27.2.1.3. SWOT Analysis
27.2.1.4. Key Developments
27.2.1.5. Key Strategy
27.2.2. Regeneron Pharmaceuticals, Inc.
27.2.3. Bausch & Lomb
27.2.4. Novartis AG
27.2.5. Allergan
27.2.6. Alimera Sciences
27.2.7. ThromboGenics, Inc.
27.2.8. Bristol-Myers Squibb Company
28. Assumptions and Acronyms Used
29. Research Methodology
Table 1: Expenditure on Health, (% of GDP), by Country, 2016 - 2021
Table 2: Global Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Drug Class
Table 3: Global Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Indication
Table 4: Global Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Distributional Channel
Table 5: Global Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Region
Table 6: North America Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country
Table 7: North America Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Drug Class
Table 8: North America Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Indication
Table 9: North America Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Distributional Channel
Table 10: Latin America Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country
Table 11: Latin America Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Drug Class
Table 12: Latin America Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Indication
Table 13: Latin America Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Distributional Channel
Table 14: Europe Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country
Table 15: Europe Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Drug Class
Table 16: Europe Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Indication
Table 17: Europe Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Distributional Channel
Table 18: South Asia Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country
Table 19: South Asia Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Drug Class
Table 20: South Asia Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Indication
Table 21: South Asia Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Distributional Channel
Table 22: East Asia Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country
Table 23: East Asia Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Drug Class
Table 24: East Asia Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Indication
Table 25: East Asia Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Distributional Channel
Table 26: Oceania Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country
Table 27: Oceania Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Drug Class
Table 28: Oceania Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Indication
Table 29: Oceania Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Distributional Channel
Table 30: Middle East and Africa Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Country
Table 31: Middle East and Africa Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Drug Class
Table 32: Middle East and Africa Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Indication
Table 33: Middle East and Africa Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Distributional Channel
Table 34: China Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Drug Class
Table 35: China Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Indication
Table 36: China Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Distributional Channel36
Table 37: India Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Drug Class
Table 38: India Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Indication
Table 39: India Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Distributional Channel
Table 40: Mexico Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Drug Class
Table 41: Mexico Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Indication
Table 42: Mexico Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Distributional Channel
Figure 1: Global Intravitreal (IVT) Injectables Market Value (US$ Mn), by Regions
Figure 2: Global Intravitreal (IVT) Injectables Market Value Share By Drug Class (2018)
Figure 3: Global Intravitreal (IVT) Injectables Market Value Share By Indication (2018)
Figure 4: Global Intravitreal (IVT) Injectables Market Value Share By Distributional Channel (2018)
Figure 5: Global Healthcare Expenditure in US$ Tn (2013–2020)
Figure 6: Global Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Drug Class
Figure 7: Global Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Indication
Figure 8: Global Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Distributional Channel
Figure 9: Global Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2028, By Region
Figure 10: North America Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis, 2013–2017
Figure 11: North America Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis, 2017–2028
Figure 12: North America Intravitreal (IVT) Injectables Market Analysis by Country –2018 & 2028
Figure 13: North America Intravitreal (IVT) Injectables Market Y-o-Y Growth Projections by Country, 2018 – 2028
Figure 14: North America Intravitreal (IVT) Injectables Market Attractiveness Analysis by Country, 2018 – 2028
Figure 15: North America Intravitreal (IVT) Injectables Market Analysis by Drug Class –2018 & 2028
Figure 16: North America Intravitreal (IVT) Injectables Market Y-o-Y Growth Projections by Drug Class, 2018 – 2028
Figure 17: North America Intravitreal (IVT) Injectables Market Attractiveness Analysis by Drug Class, 2018 – 2028
Figure 18: North America Intravitreal (IVT) Injectables Market Analysis by Indication–2018 & 2028
Figure 19: North America Intravitreal (IVT) Injectables Market Y-o-Y Growth Projections by Indication, 2018 – 2028
Figure 20: North America Intravitreal (IVT) Injectables Market Attractiveness Analysis by Indication, 2018 – 2028
Figure 21: North America Intravitreal (IVT) Injectables Market Analysis by Distributional Channel –2018 & 2028
Figure 22: North America Intravitreal (IVT) Injectables Market Y-o-Y Growth Projections by Distributional Channel, 2018 – 2028
Figure 23: North America Intravitreal (IVT) Injectables Market Attractiveness Analysis by Distributional Channel , 2018 – 2028
Figure 24: Latin America Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis, 2013–2017
Figure 25: Latin America Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis, 2017–2028
Figure 26: Latin America Intravitreal (IVT) Injectables Market Analysis by Country –2018 & 2028
Figure 27: Latin America Intravitreal (IVT) Injectables Market Y-o-Y Growth Projections by Country, 2018 – 2028
Figure 28: Latin America Intravitreal (IVT) Injectables Market Attractiveness Analysis by Country, 2018 – 2028
Figure 29: Latin America Intravitreal (IVT) Injectables Market Analysis by Drug Class –2018 & 2028
Figure 30: Latin America Intravitreal (IVT) Injectables Market Y-o-Y Growth Projections by Drug Class, 2018 – 2028
Figure 31: Latin America Intravitreal (IVT) Injectables Market Attractiveness Analysis by Drug Class, 2018 – 2028
Figure 32: Latin America Intravitreal (IVT) Injectables Market Analysis by Indication–2018 & 2028
Figure 33: Latin America Intravitreal (IVT) Injectables Market Y-o-Y Growth Projections by Indication, 2018 – 2028
Figure 34: Latin America Intravitreal (IVT) Injectables Market Attractiveness Analysis by Indication, 2018 – 2028
Figure 35: Latin America Intravitreal (IVT) Injectables Market Analysis by Distributional Channel –2018 & 2028
Figure 36: Latin America Intravitreal (IVT) Injectables Market Y-o-Y Growth Projections by Distributional Channel, 2018 – 2028
Figure 37: Latin America Intravitreal (IVT) Injectables Market Attractiveness Analysis by Distributional Channel , 2018 – 2028
Figure 38: Europe Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis, 2013–2017
Figure 39: Europe Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis, 2017–2028
Figure 40: Europe Intravitreal (IVT) Injectables Market Analysis by Country –2018 & 2028
Figure 41: Europe Intravitreal (IVT) Injectables Market Y-o-Y Growth Projections by Country, 2018 – 2028
Figure 42: Europe Intravitreal (IVT) Injectables Market Attractiveness Analysis by Country, 2018 – 2028
Figure 43: Europe Intravitreal (IVT) Injectables Market Analysis by Drug Class –2018 & 2028
Figure 44: Europe Intravitreal (IVT) Injectables Market Y-o-Y Growth Projections by Drug Class, 2018 – 2028
Figure 45: Europe Intravitreal (IVT) Injectables Market Attractiveness Analysis by Drug Class, 2018 – 2028
Figure 46: Europe Intravitreal (IVT) Injectables Market Analysis by Indication–2018 & 2028
Figure 47: Europe Intravitreal (IVT) Injectables Market Y-o-Y Growth Projections by Indication, 2018 – 2028
Figure 48: Europe Intravitreal (IVT) Injectables Market Attractiveness Analysis by Indication, 2018 – 2028
Figure 49: Europe Intravitreal (IVT) Injectables Market Analysis by Distributional Channel –2018 & 2028
Figure 50: Europe Intravitreal (IVT) Injectables Market Y-o-Y Growth Projections by Distributional Channel, 2018 – 2028
Figure 51: Europe Intravitreal (IVT) Injectables Market Attractiveness Analysis by Distributional Channel , 2018 – 2028
Figure 52: South Asia Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis, 2013–2017
Figure 53: South Asia Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis, 2017–2028
Figure 54: South Asia Intravitreal (IVT) Injectables Market Analysis by Country –2018 & 2028
Figure 55: South Asia Intravitreal (IVT) Injectables Market Y-o-Y Growth Projections by Country, 2018 – 2028
Figure 56: South Asia Intravitreal (IVT) Injectables Market Attractiveness Analysis by Country, 2018 – 2028
Figure 57: South Asia Intravitreal (IVT) Injectables Market Analysis by Drug Class –2018 & 2028
Figure 58: South Asia Intravitreal (IVT) Injectables Market Y-o-Y Growth Projections by Drug Class, 2018 – 2028
Figure 59: South Asia Intravitreal (IVT) Injectables Market Attractiveness Analysis by Drug Class, 2018 – 2028
Figure 60: South Asia Intravitreal (IVT) Injectables Market Analysis by Indication–2018 & 2028
Figure 61: South Asia Intravitreal (IVT) Injectables Market Y-o-Y Growth Projections by Indication, 2018 – 2028
Figure 62: South Asia Intravitreal (IVT) Injectables Market Attractiveness Analysis by Indication, 2018 – 2028
Figure 63: South Asia Intravitreal (IVT) Injectables Market Analysis by Distributional Channel –2018 & 2028
Figure 64: South Asia Intravitreal (IVT) Injectables Market Y-o-Y Growth Projections by Distributional Channel, 2018 – 2028
Figure 65: South Asia Intravitreal (IVT) Injectables Market Attractiveness Analysis by Distributional Channel , 2018 – 2028
Figure 66: East Asia Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis, 2013–2017
Figure 67: East Asia Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis, 2017–2028
Figure 68: East Asia Intravitreal (IVT) Injectables Market Analysis by Country –2018 & 2028
Figure 69: East Asia Intravitreal (IVT) Injectables Market Y-o-Y Growth Projections by Country, 2018 – 2028
Figure 70: East Asia Intravitreal (IVT) Injectables Market Attractiveness Analysis by Country, 2018 – 2028
Figure 71: East Asia Intravitreal (IVT) Injectables Market Analysis by Drug Class –2018 & 2028
Figure 72: East Asia Intravitreal (IVT) Injectables Market Y-o-Y Growth Projections by Drug Class, 2018 – 2028
Figure 73: East Asia Intravitreal (IVT) Injectables Market Attractiveness Analysis by Drug Class, 2018 – 2028
Figure 74: East Asia Intravitreal (IVT) Injectables Market Analysis by Indication–2018 & 2028
Figure 75: East Asia Intravitreal (IVT) Injectables Market Y-o-Y Growth Projections by Indication, 2018 – 2028
Figure 76: East Asia Intravitreal (IVT) Injectables Market Attractiveness Analysis by Indication, 2018 – 2028
Figure 77: East Asia Intravitreal (IVT) Injectables Market Analysis by Distributional Channel –2018 & 2028
Figure 78: East Asia Intravitreal (IVT) Injectables Market Y-o-Y Growth Projections by Distributional Channel, 2018 – 2028
Figure 79: East Asia Intravitreal (IVT) Injectables Market Attractiveness Analysis by Distributional Channel , 2018 – 2028
Figure 80: Oceania Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis, 2013–2017
Figure 81: Oceania Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis, 2017–2028
Figure 82: Oceania Intravitreal (IVT) Injectables Market Analysis by Country –2018 & 2028
Figure 83: Oceania Intravitreal (IVT) Injectables Market Y-o-Y Growth Projections by Country, 2018 – 2028
Figure 84: Oceania Intravitreal (IVT) Injectables Market Attractiveness Analysis by Country, 2018 – 2028
Figure 85: Oceania Intravitreal (IVT) Injectables Market Analysis by Drug Class –2018 & 2028
Figure 86: Oceania Intravitreal (IVT) Injectables Market Y-o-Y Growth Projections by Drug Class, 2018 – 2028
Figure 87: Oceania Intravitreal (IVT) Injectables Market Attractiveness Analysis by Drug Class, 2018 – 2028
Figure 88: Oceania Intravitreal (IVT) Injectables Market Analysis by Indication–2018 & 2028
Figure 89: Oceania Intravitreal (IVT) Injectables Market Y-o-Y Growth Projections by Indication, 2018 – 2028
Figure 90: Oceania Intravitreal (IVT) Injectables Market Attractiveness Analysis by Indication, 2018 – 2028
Figure 91: Oceania Intravitreal (IVT) Injectables Market Analysis by Distributional Channel –2018 & 2028
Figure 92: Oceania Intravitreal (IVT) Injectables Market Y-o-Y Growth Projections by Distributional Channel, 2018 – 2028
Figure 93: Oceania Intravitreal (IVT) Injectables Market Attractiveness Analysis by Distributional Channel , 2018 – 2028
Figure 94: Middle East and Africa Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis, 2013–2017
Figure 95: Middle East and Africa Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis, 2017–2028
Figure 96: Middle East and Africa Intravitreal (IVT) Injectables Market Analysis by Country –2018 & 2028
Figure 97: Middle East and Africa Intravitreal (IVT) Injectables Market Y-o-Y Growth Projections by Country, 2018 – 2028
Figure 98: Middle East and Africa Intravitreal (IVT) Injectables Market Attractiveness Analysis by Country, 2018 – 2028
Figure 99: Middle East and Africa Intravitreal (IVT) Injectables Market Analysis by Drug Class –2018 & 2028
Figure 100: Middle East and Africa Intravitreal (IVT) Injectables Market Y-o-Y Growth Projections by Drug Class, 2018 – 2028
Figure 101: Middle East and Africa Intravitreal (IVT) Injectables Market Attractiveness Analysis by Drug Class, 2018 – 2028
Figure 102: Middle East and Africa Intravitreal (IVT) Injectables Market Analysis by Indication–2018 & 2028
Figure 103: Middle East and Africa Intravitreal (IVT) Injectables Market Y-o-Y Growth Projections by Indication, 2018 – 2028
Figure 104: Middle East and Africa Intravitreal (IVT) Injectables Market Attractiveness Analysis by Indication, 2018 – 2028
Figure 105: Middle East and Africa Intravitreal (IVT) Injectables Market Analysis by Distributional Channel –2018 & 2028
Figure 106: Middle East and Africa Intravitreal (IVT) Injectables Market Y-o-Y Growth Projections by Distributional Channel, 2018 – 2028
Figure 107: Middle East and Africa Intravitreal (IVT) Injectables Market Attractiveness Analysis by Distributional Channel , 2018 – 2028
Figure 108: Emerging Countries Market Value Share (2018)
Figure 109: Emerging Countries Intravitreal Injectables Market Value (US$ Mn), By Key Countries, 2017-2028
Figure 110: China Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis, 2013–2017
Figure 111: China Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis, 2017–2028
Figure 112: China Intravitreal (IVT) Injectables Market Analysis by Drug Class –2018 & 2028
Figure 113: China Intravitreal (IVT) Injectables Market Y-o-Y Growth Projections by Drug Class, 2018 – 2028
Figure 114: China Intravitreal (IVT) Injectables Market Attractiveness Analysis by Drug Class, 2018 – 2028
Figure 115: China Intravitreal (IVT) Injectables Market Analysis by Indication–2018 & 2028
Figure 116: China Intravitreal (IVT) Injectables Market Y-o-Y Growth Projections by Indication, 2018 – 2028
Figure 117: China Intravitreal (IVT) Injectables Market Attractiveness Analysis by Indication, 2018 – 2028
Figure 118: China Intravitreal (IVT) Injectables Market Analysis by Distributional Channel –2018 & 2028
Figure 119: China Intravitreal (IVT) Injectables Market Y-o-Y Growth Projections by Distributional Channel, 2018 – 2028
Figure 120: China Intravitreal (IVT) Injectables Market Attractiveness Analysis by Distributional Channel , 2018 – 2028
Figure 121: India Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis, 2013–2017
Figure 122: India Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis, 2017–2028
Figure 123: India Intravitreal (IVT) Injectables Market Analysis by Drug Class –2018 & 2028
Figure 124: India Intravitreal (IVT) Injectables Market Y-o-Y Growth Projections by Drug Class, 2018 – 2028
Figure 125: India Intravitreal (IVT) Injectables Market Attractiveness Analysis by Drug Class, 2018 – 2028
Figure 126: India Intravitreal (IVT) Injectables Market Analysis by Indication–2018 & 2028
Figure 127: India Intravitreal (IVT) Injectables Market Y-o-Y Growth Projections by Indication, 2018 – 2028
Figure 128: India Intravitreal (IVT) Injectables Market Attractiveness Analysis by Indication, 2018 – 2028
Figure 129: India Intravitreal (IVT) Injectables Market Analysis by Distributional Channel –2018 & 2028
Figure 130: India Intravitreal (IVT) Injectables Market Y-o-Y Growth Projections by Distributional Channel, 2018 – 2028
Figure 131: India Intravitreal (IVT) Injectables Market Attractiveness Analysis by Distributional Channel , 2018 – 2028
Figure 132: Mexico Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis, 2013–2017
Figure 133: Mexico Intravitreal (IVT) Injectables Market Size (US$ Mn) Analysis, 2017–2028
Figure 134: Mexico Intravitreal (IVT) Injectables Market Analysis by Drug Class –2018 & 2028
Figure 135: Mexico Intravitreal (IVT) Injectables Market Y-o-Y Growth Projections by Drug Class, 2018 – 2028
Figure 136: Mexico Intravitreal (IVT) Injectables Market Attractiveness Analysis by Drug Class, 2018 – 2028
Figure 137: Mexico Intravitreal (IVT) Injectables Market Analysis by Indication–2018 & 2028
Figure 138: Mexico Intravitreal (IVT) Injectables Market Y-o-Y Growth Projections by Indication, 2018 – 2028
Figure 139: Mexico Intravitreal (IVT) Injectables Market Attractiveness Analysis by Indication, 2018 – 2028
Figure 140: Mexico Intravitreal (IVT) Injectables Market Analysis by Distributional Channel –2018 & 2028
Figure 141: Mexico Intravitreal (IVT) Injectables Market Y-o-Y Growth Projections by Distributional Channel, 2018 – 2028
Figure 142: Mexico Intravitreal (IVT) Injectables Market Attractiveness Analysis by Distributional Channel , 2018 – 2028
Figure 143: Revenue (US$) & Y-o-Y Growth (%), 2014–2017
Figure 144: Revenue (US$) & Y-o-Y Growth (%), 2014–2017
Figure 145: Revenue (US$) & Y-o-Y Growth (%), 2014–2017
Figure 146: Revenue (US$) & Y-o-Y Growth (%), 2014–2017
Figure 147: Revenue (US$) & Y-o-Y Growth (%), 2014–2017
Figure 148: Revenue (US$) & Y-o-Y Growth (%), 2014–2017
